Patent Number: 6,251,682

Title: Method and markers for prognosticating efficacy of anticancer agents

Abstract: Methods and markers for prognosticating the efficacy of anti-cancer agents in patients suffering from cancer by detection of mutant tubulin genes are provided.

Inventors: Rosell; Rafael (Barcelona, ES), Monzo; Mariano (Barcelona, ES)

Assignee: Bristol-Myers Squibb Company

International Classification: A61K 31/337 (20060101); G01N 033/00 (); G01N 033/48 (); C07H 021/04 (); C12Q 001/68 (); C12P 019/34 ()

Expiration Date: 06/26/2018